SB 2586 In Committee
Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Sign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.